Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Long-Term Deferred Tax (2021 - 2026)

Collegium Pharmaceutical has reported Long-Term Deferred Tax over the past 5 years, most recently at $112.5 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 14.8% year-over-year to $112.5 million; the TTM value through Dec 2025 reached $112.5 million, up 14.8%, while the annual FY2025 figure was $112.5 million, 14.8% up from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $112.5 million at Collegium Pharmaceutical, up from $102.5 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $112.5 million in Q4 2025 and troughed at $24.0 million in Q4 2022.
  • A 5-year average of $54.9 million and a median of $34.2 million in 2024 define the central range for Long-Term Deferred Tax.
  • Biggest five-year swings in Long-Term Deferred Tax: tumbled 69.31% in 2022 and later soared 273.33% in 2024.
  • Year by year, Long-Term Deferred Tax stood at $78.0 million in 2021, then tumbled by 69.31% to $24.0 million in 2022, then rose by 9.64% to $26.3 million in 2023, then soared by 273.33% to $98.0 million in 2024, then rose by 14.8% to $112.5 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for COLL at $112.5 million in Q4 2025, $102.5 million in Q3 2025, and $92.0 million in Q2 2025.